The rise of Viagra and its impact on the drug landscape presents a complex question for investors. While the early sales data were astounding, the exclusivity has lapsed, leading to a deluge of off-brand alternatives https://laylaropz461726.blogoscience.com/48106521/the-blue-pill-and-the-pharmaceutical-industry-a-dangerous-opportunity